Finnish biotechnology company Biohit Oyj (HEL:BIOBV) on Friday introduced the Biohit FAEX Sample System, a new stool sample collection and handling solution designed for seamless integration into diagnostic workflows.
According to Biohit, the system enhances precision, efficiency and flexibility for both patients and laboratories.
The Biohit FAEX Sample System functions as both a standard test tube and a dropper tube, ensuring accurate and reproducible sample dispensing for ELISAs, chemiluminescence assays, lateral flow tests and proprietary diagnostic kits. A precision-engineered collection stick enables consistent sample collection, while a screw-tight cap with leak-proof threads ensures safe handling, transport and storage.
CE-marked and compliant with Regulation (EU) 2017/746 for In Vitro Diagnostic Devices, the system meets high regulatory standards. It can be used as a standalone component or as part of a diagnostic kit, offering a practical and reliable solution for stool sample processing.
Femasys receives CE mark approval for FemBloc delivery system in Europe
Avance Biosciences registers with CLIA program
Abbott announces quarterly common dividend
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke
Median Technologies secures funding for eyonis Lung Cancer Screening software